Cash Flow Kidswell Bio Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
72.00
-1,420.00
-656.00
-549.00
-999.00
-7,314.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
897.00
911.00
-824.00
-225.00
-274.00
-154.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
936.00
-453.00
-1,421.00
-1,169.00
-1,267.00
-1,325.00
Cash Flow from Investing Activities
65.00
0.00
-28.00
526.00
-22.00
-137.00
Cash Flow from Financing Activities
-240.00
1,617.00
1,356.00
369.00
718.00
1,221.00
Net Cash Inflow / Outflow
764.00
1,164.00
-93.00
-273.00
-571.00
-240.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
2.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kidswell Bio Corp.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
72.867
-761.301
833.00
109.57%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
897.505
87.426
810.00
926.59%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
936.707
-534.793
1,470.00
275.15%
Cash Flow from Investing Activities
65.077
-397.564
462.00
116.37%
Cash Flow from Financing Activities
-240.061
1256.323
-1,496.00
-119.11%
Net Cash Inflow / Outflow
764.022
323.966
441.00
135.83%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
2.299
0
2.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 306.49% vs 68.08% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
936.71
-453.63
306.49%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
